Health Dictionary Find a Doctor

Portal vein thrombosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

It seems portal vein thrombosis is caused by Virchow’s triad which includes: Reduced portal blood flow, hypercoagulable state, and vascular endothelial injury. There are two mechanisms that contribute in loss of portal vein blood flow to liver, arterial rescue and venous rescue. It is a rapid process and takes a few days to start and 3-5 weeks to complete after portal vein obstruction. Collateral vessel joins to form cavernoma which connects the proximal and distal part of thrombosed portal vein. Finally, the portal vein becomes a fibrosed and thin cord. All these events leads to low systemic vascular resistance and high. These are the characterstic findings of hyperkinetic circulation.

Structure

Tributaries

The tributaries of the hepatic portal vein include:

Pathophysiology

Pathogenesis

<figure-inline><figure-inline><figure-inline><figure-inline></figure-inline></figure-inline></figure-inline></figure-inline>

Shown below is a table depicting the elements of Virchow’s triad and their modern counterparts.

Virchow’s[2] Modern Notes
Phenomena of interrupted blood-flow “Stasis” or “venous stasis[3]
Phenomena associated with irritation of the vessel and its vicinity “Endothelial injury” or “vessel wall injury”
Phenomena of bloodcoagulation Hypercoagulability

Genetics

  • The development of portal vein thrombosis is the result of G201210A mutations.

Associated Conditions

Gross Pathology

Microscopic Pathology

  • There is no finding on microscopic histopathological analysis.

References

  1. 1.0 1.1 Chawla YK, Bodh V (2015). “Portal vein thrombosis”. J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
  2. Agutter, Paul S. (2008). The Aetiology of Deep Venous Thrombosis: A Critical, Historical and Epistemological Survey. Berlin: Springer. p. 84. ISBN 1-4020-6649-X.
  3. Lowe GD (2003). “Virchow’s triad revisited: abnormal flow”. Pathophysiol. Haemost. Thromb. 33 (5–6): 455–7. doi:10.1159/000083845. PMID 15692260.
  4. “Further reflections on Virchow’s triad. – Free Online Library”. Retrieved 2009-02-10.
  5. Chung I, Lip GY (2003). “Virchow’s triad revisited: blood constituents”. Pathophysiol. Haemost. Thromb. 33 (5–6): 449–54. doi:10.1159/000083844. PMID 15692259.
  6. Zhang WW, Churchill S, Churchill P (1989). “Developmental regulation of D-beta-hydroxybutyrate dehydrogenase in rat liver and brain”. FEBS Lett. 256 (1–2): 71–4. PMID 2806552.
  7. Henderson JM, Gilmore GT, Mackay GJ, Galloway JR, Dodson TF, Kutner MH (1992). “Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows”. Hepatology. 16 (3): 715–8. PMID 1505914.
  8. De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K (1995). “Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography”. AJR Am J Roentgenol. 165 (5): 1151–5. doi:10.2214/ajr.165.5.7572494. PMID 7572494.
  9. Hoekstra J, Janssen HL (2009). “Vascular liver disorders (II): portal vein thrombosis”. Neth J Med. 67 (2): 46–53. PMID 19299846.
  10. Wang JT, Zhao HY, Liu YL (2005). “Portal vein thrombosis”. HBPD INT. 4 (4): 515–8. PMID 16286254.
  11. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D (2001). “Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy”. Gastroenterology. 120 (2): 490–7. PMID 11159889.
  12. Garcia-Pagán JC, Hernández-Guerra M, Bosch J (2008). “Extrahepatic portal vein thrombosis”. Semin. Liver Dis. 28 (3): 282–92. doi:10.1055/s-0028-1085096. PMID 18814081.

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH